Resistance mechanisms to mTOR inhibition in renal cancer
<p><b>Introduction</b>: Advanced clear cell renal cell cancer (CCRCC) is incurable, but molecularly targeted treatments have improved the prognosis. One such molecular target is the mammalian target of rapamycin (mTOR) and two rapalogues (everolimus and temsirolimus) have been lice...
Үндсэн зохиолч: | Earwaker, P |
---|---|
Бусад зохиолчид: | Macaulay, V |
Формат: | Дипломын ажил |
Хэл сонгох: | English |
Хэвлэсэн: |
2015
|
Ижил төстэй зүйлс
-
The effects of mTOR inhibition in ischemic stroke
-н: Schneider, AM
Хэвлэсэн: (2022) -
mTOR Inhibition and Tuberous Sclerosis Prevention
-н: J Gordon Millichap
Хэвлэсэн: (2013-09-01) -
mTOR Signaling in Metabolism and Cancer
-н: Shile Huang
Хэвлэсэн: (2020-10-01) -
mTOR Dysregulation, Insulin Resistance, and Hypertension
-н: Silviu Marcel Stanciu, зэрэг
Хэвлэсэн: (2024-08-01) -
mTOR Inhibition: From Aging to Autism and Beyond
-н: Matt Kaeberlein
Хэвлэсэн: (2013-01-01)